Your browser doesn't support javascript.
loading
Diagnóstico y tratamiento de la trombosis venosa profunda / No disponible
Páramo, JA; Ruiz de Gaona, E; García, R; Rodríguez, P; Lecumberri, R.
Affiliation
  • Páramo, JA; Universidad de Navarra. Clínica Universitaria. Navarra. España
  • Ruiz de Gaona, E; Universidad de Navarra. Clínica Universitaria. Navarra. España
  • García, R; Universidad de Navarra. Clínica Universitaria. Navarra. España
  • Rodríguez, P; Universidad de Navarra. Clínica Universitaria. Navarra. España
  • Lecumberri, R; Universidad de Navarra. Clínica Universitaria. Navarra. España
Rev. Med. Univ. Navarra ; 51(1): 13-17, ene.-mar. 2007. ilus, tab
Article in Es | IBECS | ID: ibc-057571
Responsible library: ES1.1
Localization: ES1.1 - BNCS
RESUMEN
La trombosis venosa profunda (TVP) es un proceso frecuente que causa complicaciones como el síndrome postfl ebítico y el embolismo pulmonar, que puede ser mortal. En la actualidad un algoritmo que combina la probabilidad clínica, el dímero D y la ecografía venosa permite una estimación adecuada y no invasiva de la TVP. La base del tratamiento inicial de la TVP es la anticoagulación, fundamentalmente con heparinas de bajo peso molecular o pentasacárido (fondaparinux) que permiten el manejo ambulatorio de forma efi caz y segura. La duración del tratamiento depende de si la TVP es idiopática o secundaria a un factor de riesgo transitorio. La trombolisis y el empleo de fi ltro en la vana cava se reservan para situaciones especiales
ABSTRACT
Deep-vein thrombosis (DVT) is a common condition that can lead to complications such as postphlebitic syndrome, pulmonary embolism and death. Currently, an algorithm strategy combining pretest probability, D-dimer testing and compression ultrasonography imaging allows for safe and convenient estimation of suspected lower-limb thrombosis. The mainstay of treatment is anticoagulation therapy. The use of lowmolecular- weight heparin or pentasaccharide (fondaparinux) allows for outpatient management of most patients with DVT. The duration of anticoagulation depends on whether the primary event was idiopathic or secondary to a transient risk factor. Interventions such as thrombolysis and placement of inferior vena cava fi lter are reserved for special situations
Subject(s)
Search on Google
Collection: National databases / Spain Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Target 3.4: Reduce premature mortality due to noncommunicable diseases / Cardiovascular Disease / Venous Thromboembolic Disease Database: IBECS Main subject: Venous Thrombosis Type of study: Diagnostic study / Risk factors Limits: Humans Language: Spanish Journal: Rev. Med. Univ. Navarra Year: 2007 Document type: Article Institution/Affiliation country: Universidad de Navarra/España
Search on Google
Collection: National databases / Spain Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Target 3.4: Reduce premature mortality due to noncommunicable diseases / Cardiovascular Disease / Venous Thromboembolic Disease Database: IBECS Main subject: Venous Thrombosis Type of study: Diagnostic study / Risk factors Limits: Humans Language: Spanish Journal: Rev. Med. Univ. Navarra Year: 2007 Document type: Article Institution/Affiliation country: Universidad de Navarra/España
...